Overall adolescent drug fatalities and the annual increase in deaths involving fentanyl slowed down in 2023 compared with ...

Allowing patients to stay in their homes to receive bispecific antibodies can make the whole cancer journey easier, explained ...

Naoto T. Ueno, MD, PhD, FACP, of the University of Hawai’I Cancer Center outlines the underrepresentation in clinical trials, ...

Women are still being excluded from cardiovascular research trials, and it has a lasting impact on heart disease treatment ...

Full-time caregivers to loved one's with Alzheimer disease or other dementias could earn over $100,000 annually if they were ...

Financial toxicity and patient and staff wellness were well explored at the Association of Cancer Care Centers (ACCC) 41st ...

Two posters presented at CHEST 2024 revealed significant racial and ethnic disparities in the hospitalization and treatment ...

Patients living with HIV in Barcelona, Spain have seen a decrease in mortality of patients in critically ill condition ...

Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of ...

Financial advocacy in health care should advocate for system change and community work to give people better access to health and well-being before they get a life-changing cancer diagnosis, said ...

Adalimumab biosimilar market shares have steadily increased, but challenges remain due to pricing strategies and limited government support, according to the Samsung Bioepis report.

One of the key highlights was the discussion of Pulmonary Embolism Response Teams (PERT), addressing controversies in PE management and focusing on personalized, patient-centered care.